ArticleProceedings of the National Academy of Sciences of the United States of America2025
HIV-1 Vif and Vpr cooperatively modulate the cell cycle to maximize per-cell virion production.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026Review
- HIV and Cancer: Insights into Viral-Mediated Oncogenesis and Immunosuppression.Pathogens (Basel, Switzerland) · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The HIV type 1 (HIV-1) accessory proteins Virion Infectivity Factor (Vif) and Viral Protein R (Vpr) are essential for efficient virus replication in vivo. Vif mediates degradation of host restriction factor APOBEC3G, while Vpr modulates the host cell proteome in ways that promote virion infectivity and viral gene expression. In cycling cells including CD4+ T cells, Vif and Vpr also severely impact cell cycle progression for reasons that remain unknown. Here, we combined live-cell imaging with virological assays to define the relative impacts of Vif and Vpr on the cell cycle and single-cell virion production. We demonstrate that Vif and Vpr's effects on the cell cycle are markedly distinct, with Vif arresting cells in mitosis, while Vpr causes a G2 phase delay followed by endoreplication and reversion of cells into a "pseudo-G1" cell state lacking G2 markers. When coexpressed, Vpr's capacity to bypass mitosis acts to suppress cytotoxicity associated with Vif-mediated cell cycle arrest, with the two proteins cooperating to extend the infected cell's time in interphase as much as fivefold. Vpr-driven endoreplication also caused duplication of transcriptionally active proviral genomes, yielding a correlative ~twofold increase in per-cell viral gene expression. Based on these findings, we propose that Vif and Vpr coordinately regulate the cell cycle to prolong the infected cell's lifespan and maximize single-cell virion output.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.